These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3738429)

  • 1. The incidence of phagocytizing plasma cells in malignant plasma cell dyscrasias.
    Kanoh T; Fujii H
    Scand J Haematol; 1986 May; 36(5):480-3. PubMed ID: 3738429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 dependence of advanced malignant plasma cell dyscrasias.
    Zhang XG; Bataille R; Widjenes J; Klein B
    Cancer; 1992 Mar; 69(6):1373-6. PubMed ID: 1540875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple myeloma terminating in the leukemic stage with lobular nucleated eccentric plasma cells: a good response to therapy.
    Otsuka T; Kimura N; Niho Y
    Nihon Ketsueki Gakkai Zasshi; 1984 Feb; 47(1):150-7. PubMed ID: 6741429
    [No Abstract]   [Full Text] [Related]  

  • 4. Phagocytic myeloma cells in asymptomatic multiple myeloma.
    Kanoh T; Saigo K
    Tohoku J Exp Med; 1987 Nov; 153(3):207-10. PubMed ID: 3433276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant association of pyroglobulinemia and cryoglobulinemia in 2 patients in multiple myeloma.
    Hatake K; Saito K
    Jpn J Med; 1982 Jan; 21(1):46-9. PubMed ID: 7200160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
    Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
    Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management.
    Rajkumar SV
    Hematology Am Soc Hematol Educ Program; 2005; ():340-5. PubMed ID: 16304401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytofluorimetric evaluation of plasma cell proliferative activity in monoclonal gammopathies.
    Triolo R; Omedè P; Giaretta F; Ravaglia R; Battaglio S; Palumbo A; Dominietto A; Argentino C; Triolo S; Pileri A; Boccadoro M
    Eur J Histochem; 1997; 41 Suppl 2():57-8. PubMed ID: 9859783
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma].
    Schleiffenbaum BE
    Praxis (Bern 1994); 2012 Nov; 101(24):1521-9; quiz 1530-1. PubMed ID: 23184544
    [No Abstract]   [Full Text] [Related]  

  • 10. Focus on myeloma and plasma cell disorders. 21-22 January 2005, Las Vegas, NV, USA.
    Walker RC
    IDrugs; 2005 Mar; 8(3):189-92. PubMed ID: 15772884
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of changes in plasma cell subsets in multiple myeloma.
    Ayliffe MJ; Davies FE; de Castro D; Morgan GJ
    Haematologica; 2007 Aug; 92(8):1135-8. PubMed ID: 17650446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contemporaneous presentation of plasma cell leukemia and multiple myeloma. Description of a clinical case with a biclonal component].
    Pasqualetti P; Casale R; Colantonio D; Natali G
    Minerva Med; 1987 Jul; 78(13):907-10. PubMed ID: 3601136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phagocytic plasma cells in a patient with multiple myeloma.
    Vanhagen PM; de Leeuw K; Hagemeijer A; Löwenberg B
    Neth J Med; 1995 Jan; 46(1):25-9. PubMed ID: 7877709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary plasma cell leukaemia.
    Sabharwal BD; Aggarwal SP; Chander K; Duggal A
    J Assoc Physicians India; 1991 May; 39(5):410-1. PubMed ID: 1960162
    [No Abstract]   [Full Text] [Related]  

  • 15. Electron microscopic studies on tumor cells of monoclonal gammopathy.
    Yang CL; Qi SL; Yu XW; Xing LS
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(4):231-6. PubMed ID: 3124096
    [No Abstract]   [Full Text] [Related]  

  • 16. Questions concerning plasma cell leukaemia.
    Lortholary P; Casassus P; Eclache V
    Nouv Rev Fr Hematol (1978); 1992; 34(3):225-31. PubMed ID: 1408733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity in plasma cell dyscrasias.
    Xu D; Zheng C; Bergenbrant S; Holm G; Björkholm M; Yi Q; Gruber A
    Br J Cancer; 2001 Mar; 84(5):621-5. PubMed ID: 11237381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ring neutrophils in plasma cell dyscrasia.
    Kanoh T
    Arch Pathol Lab Med; 1991 Feb; 115(2):178-80. PubMed ID: 1992987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features of phagocytic plasma cell myeloma].
    Ninomiya H; Nakazawa M; Aoki Y; Nakamura H; Abe T
    Rinsho Ketsueki; 1986 Dec; 27(12):2309-12. PubMed ID: 3573321
    [No Abstract]   [Full Text] [Related]  

  • 20. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A
    Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.